OncoSec Receives CE Mark Certification for its Commercial Electroporation Device "GenPulse(TM)" for the Treatment of Solid Tumors
CE mark enables commercialization of GenPulse in EU
PENNINGTON, N.J. and SAN DIEGO, April 14, 2021 -- (Healthcare Sales & Marketing Network) -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a biotechnolog... Devices, Oncology, Regulatory OncoSec Medical, GenPulse, electroporation, gene delivery device
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news